Sponsor Pipeline

Acurx Pharmaceuticals Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07513285
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection		 Recruitment opened
2026-08-13 NCT07513285
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection		 Trial sites expanded: 0 -> 15 locations
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07513285 ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection Clostridium Difficile Infection Recurrence Recruiting
Get alerts when Acurx Pharmaceuticals Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free